Demonstration of direct binding of cIAP1 degradation-promoting bestatin analogs to BIR3 domain: Synthesis and application of fluorescent bestatin ester analogs

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 11, 2008, Pages 3354-3358

  Sato, Shinichi ^a   Aoyama, Hiroshi ^a   Miyachi, Hiroyuki ^a   Naito, Mikihiko ^a   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bestatin; BIR3 domain; cIAP1; Fluorescence polarization; Photoaffinity labeling

Indexed keywords

BESTATIN DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORESCENCE POLARIZATION; HUMAN; HUMAN CELL; PHOTOAFFINITY LABELING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION; WESTERN BLOTTING;

AMINOPEPTIDASES; APOPTOSIS; FLUORESCENCE POLARIZATION; INHIBITOR OF APOPTOSIS PROTEINS; LEUCINE; LEUCYL AMINOPEPTIDASE; MOLECULAR STRUCTURE; PHOTOAFFINITY LABELS; TUMOR CELLS, CULTURED; UBIQUITINATION;

EID: 44149100029     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.04.031     Document Type: Article

References (30)

1. Vanx D.L., and Korsmeyer S.J. Cell 96 (1999) 245
2. Thompson C.B. Science 267 (1995) 1456
3. Vaux D.L., and Strasser A. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2239
4. Wyllie A.H. Eur. J. Cell. Biol. 73 (1997) 189
5. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Annu. Rev. Biochem. 68 (1999) 383
6. Garrido C., and Kroemer G. Curr. Opin. Cell Biol. 16 (2004) 639
7. Riedl S.J., and Shi Y. Nat. Rev. Mol. Cell Biol. 5 (2004) 897
8. Kroemer G., and Martin S.J. Nat. Med. 11 (2005) 725
9. Green D.R. Cell 102 (2000) 1
10. Goyal L. Cell 104 (2001) 805
11. Deveraux Q.L., and Reed J.C. Genes Dev. 13 (1999) 239
12. Salvesen G.S., and Duckett C.S. Nat. Rev. Mol. Cell Biol. 3 (2002) 401
13. Miller L.K. Trends Cell Biol. 9 (1999) 323
14. Liston P., Fong W.G., and Korneluk R.G. Oncogene 22 (2003) 8568
15. Vaux D.L., and Silke J. Nat. Rev. Mol. Cell Biol. 6 (2005) 287
16. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., and Goeddel D.V. Cell 83 (1995) 1243
17. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. Nature 388 (1997) 300
18. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. EMBO J. 16 (1997) 6914
19. Yang L.Y., and Ashwell J.D. Nature 416 (2002) 345
20. Yang Q.H., and Du C. J. Biol. Chem. 279 (2004) 16963
21. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., Zobel K., Dynek J.N., Eliott L.O., Wallweber H.J.A., Flygare J.A., Fairbrother W.J., Deshayes K., Dixit V.M., and Vucic D. Cell 131 (2007) 669
22. Sato S., Tetsuhashi M., Sekine K., Miyachi H., Naito M., Hashimoto Y., and Aoyama H. Bioorg. Med. Chem. 16 (2008) 4685
23. Umezawa H., Aoyagi T., Suda H., Hamada M., and Takeuchi T. J. Antibiot. 29 (1976) 97
24. Leyhausen G., Gramzow M., Zahn R.K., Steffen R., Umezawa H., and Müller W.E.G. J. Antibiot. 36 (1983) 728
25. Nakamura H., Suda H., Takita T., Aoyagi T., Umezawa H., and Iitaka Y. J. Antibiot. 29 (1976) 102
26. Sekine K., Takubo K., Nishimoto M., Kitagawa M., Abe F., Nishikawa K., Tsuruo T., and Naito M. J. Biol. Chem. 283 (2008) 8961
27. Sawada T., Kato Y., Kobayashi H., Hashimoto Y., Watanabe T., Sugiyama Y., and Iwasaki S. Bioconjugate Chem. 4 (1993) 284
28. Shimazawa R., Sanda R., Mizoguchi H., Hashimoto Y., Iwasaki S., Tanaka H., Kagechika H., and Shudo K. Biochem. Biophys. Res. Commun. 179 (1991) 259
29. +.
30. 3 asymmetric stretch).